關於 cookie 的說明

本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。

會員資訊Member Info

由PR Newswire 美通社張貼的訊息， 共 47378 篇 ，以下為 10777 - 10800 篇 訂閱此列表，掌握最新動態
Global Business News
Approx. USD 4.0 M Invested in Product Development for NTDs - GHIT's First Investment in the Development of Diagnostics for Trachoma

TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 578 million (USD 4.0 million1) in four projects for the development of new diagnostics and drugs for neglected tropical diseases (NTDs) and malaria. 2  GHIT's First Investment of Approximately JPY 280 Million (USD 2.0 Million1) in the Development of a Rapid Diagnostic Test for TrachomaTrachoma, caused by infection of the conjunctiva (upper inner eyelid) by the bacterium Chlamydia trachomatis, is a neglected tropical disease (NTD) prevalent primarily in areas with poor sanitation. As the disease progresses, it eventually leads to blindness. Trachoma remains a public health issue in 39 countries, with over 103 million people at risk of infection. The disease spreads through contact with hands, clothing, bedding, and other surfaces, as well as through flies that come into contact with eye and nose discharge from infected individuals. 3 The World Health Organization (WHO) has set a goal to eliminate trachoma as a public health problem by 2030, and rapid and accurate diagnosis is critical in achieving this target. In order to overcome this situation, the GHIT Fund has decided to invest approximately JPY 280 million (USD 2.0 million1) in a project led by US-based non-profit organization Drugs & Diagnostics for Tropical Diseases (DDTD), in collaboration with Medical & Biological Laboratories, Co. Ltd. (MBL) in Japan, The Carter Center (TCC, USA), and Big Eye Diagnostics, Inc. (BEDx, USA), with active support from the Centers for Disease Control and Prevention (CDC), to develop a Rapid Diagnostic Test (RDT) kit for trachoma. This is the first time for the GHIT Fund to support product development targeting trachoma. The project is expected to enable early detection and appropriate treatment for over 100 million people at risk of blindness and vision loss, significantly advancing the global goal of eliminating trachoma. In addition, the GHIT Fund has decided to invest in three product development projects targeting malaria and Chagas disease. The investments include approximately JPY 150 million (USD 1.0 million1) in an antimalarial drug discovery project involving a partnership of Nagasaki University, The University of Tokyo, Shionogi & Co., Ltd., and Medicines for Malaria Venture (MMV); approximately JPY 70 million (USD 0.49 million1) in a rapid diagnostic test development project for Chagas disease involving Nagasaki University, Tulane University, and the Barcelona Institute for Global Health (ISGlobal); and approximately JPY 70 million (USD 0.48 million1) in a malaria drug discovery project involving The University of Tokyo, MMV, the University of Oxford, and the University of Dundee. Please refer to Appendix 1 for a detailed description of each project and its development stage. As of September 30, 2024, the GHIT Fund has invested in 33 projects, including 11 discovery projects, 14 preclinical projects, and 8 clinical trials. 4 The total amount of investments since 2013 is JPY 33.8 billion (USD 236 million) (Appendix 2). 1 USD1 = JPY142.82, the approximate exchange rate on September 30, 2024.2 These awarded projects were selected and approved as new investments from among proposals to RFP2023-002 and RFP2024-001 for the Product Development Platform, which was open for applications from November 2023 to July 2024.3 WHO: https://www.who.int/news-room/fact-sheets/detail/trachoma 4 This number includes projects in the registration phase. The GHIT Fund is a Japan-based international public-private partnership (PPP) fund that was formed between the Government of Japan, multiple pharmaceutical companies, the Bill & Melinda Gates Foundation, Wellcome, and the United Nations Development Programme (UNDP). The GHIT Fund invests in and manages an R&D portfolio of development partnerships aimed at addressing neglected diseases, such as malaria, tuberculosis, and neglected tropical diseases, which afflict the world's vulnerable and underserved populations. In collaboration with global partners, the GHIT Fund mobilizes Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases.https://www.ghitfund.org/en Appendix 1. Project Details     G2024-108 Project Title A First-in-class, Fully TPP-compliant Rapid Diagnostic Test for Trachoma Surveillance: Delivering the Missing Piece in WHO's Worldwide Trachoma Elimination Efforts Collaboration Partners 1. Drugs & Diagnostics for Tropical Diseases (DDTD) (USA) 2. Medical & Biological Laboratories, Co. Ltd. (MBL) (Japan) 3. The Carter Center (TCC) (USA) 4. Big Eye Diagnostics, Inc. (BEDx) (USA) Self-funded Research Partner: Centers for Disease Control and Prevention (CDC) (USA) Disease Trachoma Intervention Diagnostics Stage Product Development Awarded Amount JPY 288,958,766  (USD 2.0 million) Status New project Summary [Project objective] The overarching objective of this project is to deliver a rapid diagnostic test (RDT) to detect exposure to Chlamydia trachomatis, the pathogen causing trachoma. Our test will meet all key criteria of WHO's Target Product Profile (TPP) for trachoma surveillance and will be delivered in both a dipstick and a cassette format.   [Project design]The project team will pursue the following 6 specific objectives: -Objective 1 (MBL): One key factor to ensure reproducible product quality is to have a constant, reliable source of the biological components of the test. MBL will be in charge of this key task and produce the C. trachomatis antigen. -Objective 2 (DDTD): A functional prototype RDT has already been generated and validated by the CDC, and subsequently reproduced and partially optimized at DDTD. This test will now be fully optimized until it satisfies all key TPP criteria. -Objective 3 (CDC): Once an optimized candidate test has been nominated by DDTD, CDC will provide an independent validation of TPP compliance in terms of sensitivity and specificity. -Objective 4 (TCC): TCC will work with the Trachoma Monitoring Laboratory to further validate the RDT for diagnostic performance and user-friendliness (feasibility) in one of the intended use cases. -Objective 5 (DDTD, BEDx): DDTD will develop a robust, ISO13485-compliant large-scale manufacturing process commensurate with the expected demand forecast of up to 700'000 tests/year and the ideal target pricing of <$5 per test required by the TPP. -Objective 6 (DDTD): DDTD will liaise with a social anthropologist and a health economist with the goal to acquire socio-economic data on optimizing test acceptance by local populations and on testing costs of programmatic surveys. Project Detail https://www.ghitfund.org/investment/portfoliodetail/detail/223/en  H2024-101 Project Title Generation of an Early Lead for a Novel Long-Acting-Injectable (LAI) Prophylaxis Anti-Malarial: Hit-to-Lead Optimization of Dimeric Alkaloidal Molecules Collaboration Partners 1. Institute of Tropical Medicine, Nagasaki University (NU-ITM) (Japan) 2. Department of Chemistry, School of Science, The University of Tokyo (Japan) 3. Shionogi & Co., Ltd. (Japan) 4. Medicines for Malaria Venture (MMV) (Switzerland) Disease Malaria Intervention Drug Stage Hit-to-Lead Awarded Amount JPY 149,816,440 (USD 1.0 million) Status New project Summary [Project objective] The project aims to optimize the hit series, prioritize the best candidates, and deliver an early lead for intra-muscular chemoprevention that meets Medicines for Malaria Venture's long-acting-injectable Early Lead Criteria. The investigation will focus on the medicinal chemistry potential of the unique natural-product-inspired hit series as novel anti-malarial agents, ensuring synthetic tractability, cost-effectiveness, and the potential for optimizing long-acting injectable relevant anti-malarial properties. Additionally, the project will explore and characterize the novel mechanism of action and access the propensity to induce resistance. [Project design] The project team will study the structure-activity relationship to define the essential features of the minimal three-dimensional pharmacophore structures, aiming to simplify their design. Scaffold diversification will be explored to enhance our compound library, with an emphasis on improving the properties of long-acting injectable compounds by maintaining low solubility, increasing metabolic stability, and achieving a balanced blend of potency, stability, and solubility. The team will continue evaluating promising leads based on established safety and effectiveness criteria and predicting their behavior in humans. This process includes assessing leads for pharmacokinetics/dynamics, potential off-target activities, and injection site reactions using animal models. Project Detail https://www.ghitfund.org/investment/portfoliodetail/detail/224/en T2024-154 Project Title Design of a universal Rapid Diagnostic Test for the detection of chronic Trypanosoma cruzi infections. Collaboration Partners 1. Nagasaki University School of Tropical Medicine and Global Health (Japan) 2. Tulane University School of Public Health and Tropical Medicine (USA) 3. Barcelona Institute for Global Health (ISGlobal) (Spain) Disease Chagas disease Intervention Diagnostics Stage Target Research Awarded Amount JPY 69,989,878  (USD 0.49 million) Status New project Summary [Project objective] The ultimate objective is to achieve a prototype RDT to detect chronic T. cruzi infections that renders a very good performance regardless of the geographic origin of the clinical samples to analyze. For that, we envisage the following specific objectives:  (1) To sequence and assemble the whole genome of underrepresented T. cruzi isolates from Mesoamerica.  (2) To analyze, with the assistance of computational methods, all available T. cruzi protein sequences for prioritization of diagnostic antigens. (3) To address the reactivity against those selected antigens by arraying them with plasma/serum samples originating from multiple Chagas disease endemic countries.  (4) To print the ultimately prioritized antigens on immunochromatographic (IC) strips for their analytical evaluation, and qualification, as a prototype POC RDT. [Project design] To reach the goal of analytically validating a new RDT prototype that hypothetically works in all regions, the project team will first need to obtain the whole genome sequences of under-represented isolates circulating in Central America and Mexico, where it is acknowledged that currently available tools have a poor performance. Then, responding to the second specific objective, the team will analyze all the sequences with the aid of computational methods in order to identify the antigens, or epitopes within them, of diagnostic interest. In search of the antigenic sequences that could encompass a pan-American, or regionally tailored, serological tool, we will consider evolutionary conservation as a major feature. For evaluating the prioritized peptide sequences derived from the computational analysis, the team will use a collection of samples from T. cruzi-infected individuals, and geographically matched non-infected controls. For the sake of time, this collection will be retrospective, and it will encompass two sets of samples: one for the exploratory part of the project, and another for the validation of the sequences. The teamr will address the reactivity of the samples over the distinct peptide sequences by means of peptide microarrays. These will render the necessary throughput to be able to check hundreds of peptides. Those supporting the widest geographical coverage and yielding the highest signal will be selected. Finally, the best will be taken to generate the RDT prototype in the shape of a lateral flow assay. Project Detail https://www.ghitfund.org/investment/portfoliodetail/detail/225/en T2023-158 Project Title Fragment and structure-based hit generation platform for new malaria targets Collaboration Partners 1. University of Tokyo (Japan) 2. Medicines for Malaria Venture (MMV) (Switzerland) 3. University of Oxford (UK) 4. University of Dundee (UK) Disease Malaria Intervention Drug Stage Target Research Awarded Amount JPY 69,962,310 (USD 0.48 million) Status New project Summary [Project objective] The goal of the project is to generate high quality hit compound series against two highly validated malarial targets, by applying, for the first time in malaria, the state-of-the-art XChem fragment approach of X-ray structure-accelerated, synthesis-aligned lead discovery. The targets, Pf DPCK and Pf KRS are essential, novel Plasmodium targets prioritized by the malaria drug discovery community. There is a need for high quality chemical matter to serve as starting points for further optimization. [Project design] Crystallization conditions on the two selected biological targets will be optimized to enable large-scale production of protein crystals (~1000) that consistently diffract to a high resolution (preferably <2.5 Å).  Each crystal will then be soaked separately with a fragment from a library that was optimized to cover chemical space and designed to allow rapid, cheap follow-up synthesis to provide quick structure activity data. Solving the crystal structure of fragments that bind to the target gives an understanding of how that compound binds to the target and allows the team to then apply AI and medicinal chemistry techniques to design, then synthesize new compounds that will bind more tightly to the target. Through application of these design-make-test cycles the team will optimize the selected hits to deliver high quality drug discovery starting points.  A suite of biochemical and biophysical tools will be used to characterize the hit compounds, with advanced compounds being fully profiled for malaria lifecycle activity. Project Detail https://www.ghitfund.org/investment/portfoliodetail/detail/222/en *All amounts are listed at an exchange rate of USD1 = JPY142.82, the approximate exchange rate on September 30, 2024. Appendix 2. Investment Overview (as of September 30, 2024) Investments to date  Total investments: 33.8 billion yen (USD 236 million1)Total invested projects: 129 (33 active projects and 96 completed projects) To learn more about the GHIT Fund's investments, please visit Investment Overview: https://www.ghitfund.org/investment/overview/en Portfolio: https://www.ghitfund.org/investment/portfolio/en Advancing Portfolio: https://www.ghitfund.org/investment/advancingportfolio/en Clinical Candidates: https://www.ghitfund.org/investment/clinicalcandidates/en  For more information, contact:Katy Lenard at +1-301-280-5719 or klenard@burness.comMina Ohata at +81-36441-2032 or mina.ohata@ghitfund.org

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 211 加入收藏 :
Global Business News
Matrixport APP Launches OTC Service to Lower Barriers for Traditional Capital

SINGAPORE, Nov. 7, 2024 /PRNewswire/ -- Matrixport, the world's leading and Asia's largest one-stop financial services platform, announced the integration of Fly Wing Technologies Pte Ltd's ("Fly Wing") OTC service on the Matrixport APP, enabling a seamless one-stop experience for users. All Matrixport-verified accounts must complete Fly Wing's eKYC onboarding process to become a Fly Wing customer before gaining access to Fly Wing's OTC service. Unlike the conventional C2C services provided by crypto exchanges, the OTC service provided by Fly Wing uses bank transfers to complete fund transfers with partner banks, ensuring the assets' security and transaction transparency. The OTC service combines compliance and convenience, lowering the barriers for traditional financial investors to access crypto assets. Currently, the OTC function only supports USD, USDT, and USDC transactions. John Ge, CEO of Matrixport, stated, "Fiat currency deposits and withdrawals are the first steps in the user's crypto experience, and it is also the most important step in promoting crypto assets to the masses. In response to the growing demand for crypto asset management and the evolving regulatory landscape, we strive to deliver an OTC service that seamlessly integrates compliance and convenience to address users' concerns. We will remain attentive to user needs and continue to refine our products to enhance the crypto experience. Our goal is to position Matrixport as the gateway to a traditional user experience in Web 3.0." Recently, Matrixport has simultaneously expanded the breadth and depth of its products, continuously upgrading its trading system and features while further diversifying its structured product line. This multi-pronged approach enhances the crypto experience for users on Matrixport. With the launch of the OTC function, eligible users can engage in a range of crypto activities such as fiat currency deposits and withdrawals, transactions, lending, financial management, and on-chain staking on the APP, creating a one-stop crypto ecosystem. About Matrixport Founded in 2019, Matrixport is the world's leading all-in-one hub for crypto financial services. The platform is committed to providing every user with a personalized Super Account that integrates crypto trading, investment, loan, custody, RWA, research, and more. With $6 billion in AUM (assets under management), Matrixport offers global users diverse crypto-financial solutions designed for optimal capital efficiency and sustainable returns. As a Group and through its local subsidiaries, Matrixport has received the Trust and Company Service Provider (TCSP) / Money Lender Licenses in Hong Kong, and the FINMA Asset Management License in Switzerland. The company operates as an Appointed Representative in the UK, is registered as an MSB in the US, and is a member of Switzerland's SRO-VFQ. It was recognized by CB Insights as one of the "50 Most Promising Blockchain Companies" and featured in the Hurun "2024 Global Unicorn List." Additionally, Matrixport's subsidiary, Fly Wing, has obtained IPA for the MPI License in Singapore. Matrixport official website: https://www.matrixport.com  

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 221 加入收藏 :
Global Business News
Big wins await retailers that focus on the first and final hours of seasonal sales

Criteo research finds that online sales in the opening and closing hours of Singles Day capture over 300% increase in transaction volume across Southeast Asia SINGAPORE, Nov. 7, 2024 /PRNewswire/ -- Criteo (NASDAQ: CRTO), the commerce media company, today unveiled key insights from the 2023 Singles' Day sales across Southeast Asia (SEA) and Greater China. Singles' Day (11/11) presents an enormous opportunity for retailers in these regions to connect with consumers at crucial decision-making moments, build brand loyalty and stand out from the competition. In 2023, online retail transactions in SEA surged 140% compared to the first week of October, and the average basket size increased by 16% compared to the same baseline. In Greater China, online retail transactions grew 237% while the average basket size saw a 6% uptick. "As the year-end sales season draws near, it's timely to glean past insights to better seize the opportunities that lie ahead," said Taranjeet Singh, Managing Director, Venture Markets, APAC at Criteo. "One thing is clear: such e-commerce events hold tremendous potential and impact for brands and retailers to capitalise on the moment. In providing these datasets, we hope to empower our brand and retail partners to maximise sales opportunities and enhance customer experiences as Singles' Day draws around once more." Key findings:  1.    Singles' Day is the largest seasonal sales opportunity for retailers Across the board, all sales metrics perform higher on Singles' Day – be it online retail transactions, unit sales, and average basket sizes. This marks consumers' willingness to spend during this period, which is widely known for its festive deals, loyalty promotions, and immersive e-commerce experiences. In Southeast Asia: Online retail transactions surged by 140% compared to the first week of October 2023. In comparison, sales on Black Friday 2023 increased 101% from the first four weeks of October 2023. Unit sales, which denotes the number of individual items sold, skyrocketed by 178%, compared to 139% in 2022. During Cyber 6 (Black Friday to Cyber Wednesday 2023), sales increased 4% compared to the same period in 2022. The average basket size, which indicates the quantity of products purchased per transaction, also saw a notable uptick of 16%, compared to the first week of October 2023. The top-performing product categories, based on indexed transactions from the first week of October 2023, comprise Baby & Toddler (+407%), Health & Beauty (+352%) and Furniture (+277%).  In Greater China: Online retail transactions surged by 237% compared to the first week of October. In comparison, sales on Black Friday 2023 rose 58% from the first four weeks of October 2023. Unit sales saw a 257% increase, compared to 248% in 2022. Sales during Cyber 6 (Black Friday to Cyber Wednesday 2023) increase 2% compared to the same period in 2022. The average basket size saw an uptick of 6%, compared to the first week of October. The top-performing product categories, based on indexed transactions from the first week of October 2023, comprise: Health & Beauty (417%), Home & Garden (326%), Luggage & Bags (311%) and Toys & Games (311%). Online transactions saw a 9% Year-on-Year growth on Singles' Day. Interestingly, average order values showed an increase of 14%, with the average unit price going up by 7%. 2.     Shoppers are prepared to spend the most during the first and last hours of Singles' Day Shopper activity tends to spike in the first (12AM - 1AM) and last hours (11PM - 12AM) of the day. Early bird shoppers are a segment of shoppers who tend to prepare their shopping baskets ahead of time in anticipation of discounts and offers. These early bird shoppers represent a crucial segment for brands to capitalise on by offering flash discounts or loyalty promotions. Meanwhile, last-minute shoppers tend to seize deals available at the day's final hours – marking a final opportunity to convert buyers who hold out until the very end for a good deal. Savvy retailers that take note of this pattern will leverage their retail media platforms to drive and serve ads in the lead-up to and prior to the closing of these sales events. The first hour of Singles' Day (12AM - 1AM) sees the greatest spike in SEA online transactions (+325%) and unit sales (+370%), compared to baseline sales at the start of October. This trend is reversed in Greater China, with online transactions (+345%) and unit sales (363%) spiking in the final hour of Singles' Day (11PM - 12AM). 3.      'Tis the season to convert new buyers: conversion rates are exceptionally high during Singles' Day In the past few years, Singles' Day has consistently recorded substantial spikes in new purchases by new buyers. While the number of new buyers fell in 2023, there is still a clear opportunity to convert new customers and establish lasting customer relationships during this period. Retailers who can build on this momentum of first-time buyers during Singles' Day will also see the chance to ensure continued patronage as the holiday season progresses. Singles' Day 2023 saw a whopping 63% increase in new shoppers in SEA compared to the month of October. Taking action: Sales events such as Singles' Day are becoming more important for consumers today and represent a growing opportunity for retailers and brands. To realise the true potential of such events, retailers and brands should follow these key learnings for sales season: 1.     Starting Early Matters: with sales events recording much higher-than-average transaction figures, ensuring the relevant media collateral and sales logistics are ready in advance will be helpful to signpost and facilitate consumer purchases. Shoppers tend to plan their purchases in advance, and 47% of consumers globally[1] tend to start their search at retailers rather than search engines, when they know the general type of item they want to buy. As retail media continues to grow with new formats such as offsite and in-store, using retail media allows brands and retailers to engage shoppers further up the funnel, to aid product discovery and boost brand awareness.  Kicking off new campaigns early also ensures campaigns are optimised as shoppers start researching. Brands can also gain a sales boost by expanding their retailer sets to small or medium-size retailers. 2.     Go Full-Funnel: Retail media can help drive positive outcomes during sales events and build lasting customer relationships. Layering sponsored products and offsite campaigns push the needle in capturing new and returning customers during such events and keeping the brand or retail platform top of mind. Keeping in mind that shoppers tend to view several brands before deciding, these tactics also build brand appeal and create a strong impression with shoppers in each stage of their shopping journey. 3.     Be Diligent with Speed: There is increased shopper activity in the first and final hours of these sales events. Savvy retailers and brands drive additional sales by leveraging the data to plan budget accordingly and positioning key advertisements in front of these shoppers in those critical moments. Methodology Criteo captures organic data from 20 countries, 600 product categories and over 19,000 advertiser clients. Indexed sales are monitored on retailers who partner with Criteo Marketing Solutions and Criteo Retail Media. Criteo data includes only product categories represented by at least 5 retailers at the most granular level. Organic data means that all events from our clients, including those not attributed to Criteo, are leveraged. This allows us to produce insights regarding the market rather than Criteo campaigns. About Criteo  Criteo (NASDAQ: CRTO) is the global commerce media company that enables marketers and media owners to drive better commerce outcomes. Its industry leading Commerce Media Platform connects thousands of marketers and media owners to deliver richer consumer experiences from product discovery to purchase. By powering trusted and impactful advertising, Criteo supports an open internet that encourages discovery, innovation, and choice. For more information, please visit www.criteo.com. [1] Criteo shopper survey, Q3 2024, Global (N=7120) Criteo 2023 Holiday Shopping Season Country-Specific Findings  In Singapore: Singles' Day remains the largest seasonal sales opportunity for retailers in Singapore, with online sales skyrocketing +159% on 11/11 compared to the first four weeks of October. In comparison, sales on Black Friday 2023 surged 104%, compared to the first four weeks of October 2023. In Indonesia Singles' Day remains the largest seasonal sales opportunity for retailers in Indonesia, with online sales skyrocketing +194% on 11/11 compared to the first four weeks of October. In comparison, sales on Black Friday 2023 surged 56%, compared to the first four weeks of October 2023.  

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 227 加入收藏 :
Global Business News
Mushiny Unveils 3D Sorter Mini and MIX Pro: Leading a New Era of Efficient Warehouse Solutions

HUZHOU, China, Nov. 7, 2024 /PRNewswire/ -- Mushiny, the world's leading tech company specializing in logistics robot intelligent systems, has announced two groundbreaking solutions that redefine automation and high-density storage in the warehousing sector. These launches showcase Mushiny's commitment to innovation and efficiency, catering to a wide range of operational needs in logistics. 3D Sorter Mini: A Smart Sorting Solution Offering High Cost-Effectiveness and Quick Deployment Low cost, high efficiency, enabling optimal ROI. Small footprint; easy installation and operation for rapid deployment. Sorting efficiency reaching up to 1,500 packages per hour (pph). Sorting efficiency 2-3 times higher than manual sorting. High level of automation: seamlessly integrates with WMS, ERP, and other systems, supporting both forward and reverse logistics. Supports dual-side sorting wall deployment with up to 100 customizable slots. "The 3D Sorter Mini builds on the success of last year's 3D Sorter Max, offering an affordable and efficient solution that significantly boosts ROI," said Mushiny Founder and CTO, Huang Zhiming. In a Zhuji e-commerce project, it increased picking efficiency by 300%, reduced labor by 65%, and achieved 100% ROI within a year. The device offers flexibility, accuracy, and high operational efficiency, with strong adaptability. Mushiny 3D Sorter Mini MIX Pro High-Bay Tote Solution: Maximizing Vertical Space The MIX Pro seamlessly integrates high-density tote-to-person and conventional shelf-to-person operations, facilitating mixed storage and picking for a wide array of products. This approach assists enterprises in slashing costs and boosting efficiency, thereby delivering substantial value. Key features of MIX Pro include: - High Compatibility Storage: Supports mixed product storage and picking, adaptable to various product sizes. - Ultra-High-Density Storage: Double-deep racking with compact aisle design, reaching up to 12 meters for higher storage density. - Optimized Software Management: Incorporates mast and traffic control, automatic sorting, and shelf organization, enhancing process picking and equipment efficiency. - Lightweight Design with High ROI: Features a lightweight mechanical structure that reduces costs and failure rates. A suspended track design minimizes floor requirements, maximizing return on investment. - Modular and Flexible Application: Customizable modular design compatible with various totes and capable of interfacing with conveyor lines and AMR robots, suitable for diverse warehousing needs. - High Throughput Capacity: Horizontal and vertical speeds up to 3 m/s, with multi-mast single-aisle configuration and unified dispatch, backed by durable power supply through contact lines. - Adjustable Shelving: Accommodates potential ground settling issues in new warehouses.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 233 加入收藏 :
Global Business News
Mushiny Unveils 3D Sorter Mini and MIX Pro: Leading a New Era of Efficient Warehouse Solutions

HUZHOU, China, Nov. 7, 2024 /PRNewswire/ -- Mushiny, the world's leading tech company specializing in logistics robot intelligent systems, has announced two groundbreaking solutions that redefine automation and high-density storage in the warehousing sector. These launches showcase Mushiny's commitment to innovation and efficiency, catering to a wide range of operational needs in logistics. 3D Sorter Mini: A Smart Sorting Solution Offering High Cost-Effectiveness and Quick Deployment Low cost, high efficiency, enabling optimal ROI. Small footprint; easy installation and operation for rapid deployment. Sorting efficiency reaching up to 1,500 packages per hour (pph). Sorting efficiency 2-3 times higher than manual sorting. High level of automation: seamlessly integrates with WMS, ERP, and other systems, supporting both forward and reverse logistics. Supports dual-side sorting wall deployment with up to 100 customizable slots. "The 3D Sorter Mini builds on the success of last year's 3D Sorter Max, offering an affordable and efficient solution that significantly boosts ROI," said Mushiny Founder and CTO, Huang Zhiming. In a Zhuji e-commerce project, it increased picking efficiency by 300%, reduced labor by 65%, and achieved 100% ROI within a year. The device offers flexibility, accuracy, and high operational efficiency, with strong adaptability. Mushiny 3D Sorter Mini MIX Pro High-Bay Tote Solution: Maximizing Vertical Space The MIX Pro seamlessly integrates high-density tote-to-person and conventional shelf-to-person operations, facilitating mixed storage and picking for a wide array of products. This approach assists enterprises in slashing costs and boosting efficiency, thereby delivering substantial value. Key features of MIX Pro include: - High Compatibility Storage: Supports mixed product storage and picking, adaptable to various product sizes. - Ultra-High-Density Storage: Double-deep racking with compact aisle design, reaching up to 12 meters for higher storage density. - Optimized Software Management: Incorporates mast and traffic control, automatic sorting, and shelf organization, enhancing process picking and equipment efficiency. - Lightweight Design with High ROI: Features a lightweight mechanical structure that reduces costs and failure rates. A suspended track design minimizes floor requirements, maximizing return on investment. - Modular and Flexible Application: Customizable modular design compatible with various totes and capable of interfacing with conveyor lines and AMR robots, suitable for diverse warehousing needs. - High Throughput Capacity: Horizontal and vertical speeds up to 3 m/s, with multi-mast single-aisle configuration and unified dispatch, backed by durable power supply through contact lines. - Adjustable Shelving: Accommodates potential ground settling issues in new warehouses.  

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 253 加入收藏 :
大陸港澳
歡歌2024年度盛典「啟程•拾光」開幕，曾瑋中、邱軍攜數百位歌手傾情獻唱

台北2024年11月7日 /美通社/ -- 歡歌一年一度的年度盛典將於11/7如約而至，開啟為期一個多月的線上狂歡，數千萬用戶翹首以盼，準備大展歌喉。本次2024的年度盛典主題為「啟程•拾光」，寓意著新旅途的開啟和對過去時光的追憶，也是對歡歌邁向十週年的美好憧憬。在歡歌的世界裡，歡歌用音樂連結了過去與未來，陪伴著歡歌用戶一起成長，重拾回憶，啟程未來。 此次年度盛典，官方也是誠意滿滿，準備了一系列精彩的活動回饋廣大用戶，有「拾光代理人」、「拾來運轉」、「時光舞會」等等。用戶可以透過發佈自己的唱歌作品，參加包廂活動等方式參與，在這場全民慶典中發光發熱，盡情狂歡。 在11/7晚8點，歡歌將舉行年度盛典的開幕式線上直播表演，特別邀請到近期風靡全台的《運轉人生》、《必巡》原唱歌手來到現場：《明日之星Super Star》元老級選手-曾瑋中，以及《聲林之王3》的亞軍-邱軍，他們將會親臨歡歌直播間（歌房ID：11），與歡歌裡的歌手一起，給大家呈現精彩的視聽盛宴，為歡歌獻上祝福，並會接受獨家訪問，與歌友們親密互動。而在12/14，歡歌將會舉辦年度盛典的線下晚會，與歡歌用戶共襄盛舉。屆時，眾多歌手都將親臨現場，獻上精彩的唱歌表演。晚會現場將會佈置有趣的打卡點供來賓拍照留念，也將會為表現傑出的歡歌用戶頒發榮譽獎項。官方也準備了多輪好玩的遊戲與抽獎環節，來賓將有機會獲得卡拉獸等獨家周邊！ 歡歌年度盛典，在每一年的尾牙都會如期而至，並精心策劃一系列精彩的活動與表演，讓全體用戶享受音樂盛宴。這種年復一年的陪伴，是對用戶矢志不渝的承諾，也是對歡歌用戶的深情告白。明星藝人的傾情加入，也為這場視聽盛宴打上一劑強心針。對歡歌來說，這是一年一度的感恩回饋派對，用音樂讓用戶獲得歸屬感，增強社區的凝聚力。來自天涯海角且志同道合的歌友，在歡歌相聚一堂，回歸音樂，互相交流，切磋技巧，碰撞出更多的火花。從更大的角度看，年度盛典也推動了音樂文化的傳播和發展，為大家創造了一個和諧有愛的音樂世界。 回顧2024年，這一年也是歡歌的豐收之年。在這一年裡，歡歌舉辦Y2K年代歌謠祭，邀請歌手陳勢安與張秀卿，在歡歌直播間獻上精彩的千禧年金曲秀；歡歌舉辦第三季達人戰隊賽，讓各路網紅與粉絲報團取暖，用音樂秀實力；歡歌聯手東森電視台推出全台首檔樂團綜藝選秀節目《一起聽團吧》，用專業的網路技術和火爆的話題，為新生代音樂人造夢；歡歌贊助那那大師演唱會，讓演唱會粉絲相聚在歡歌歌房狂歡互動；歡歌聯名新秀美妝品牌蓓朵娜，跨界推出「此刻我要C位出道」的音樂話題營銷，火爆全網...在即將到來的2025年，歡歌會再接再厲，堅持以「用戶體驗為中心」的服務原則，與更多藝人，更多產業合作，打造一個更加多元、有趣、繁榮的泛娛樂音樂生態！

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 578 加入收藏 :
西南財經大學第七屆國際金融科技論壇在新加坡舉行
發表時間 :
Aquaron Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
發表時間 :
M31 Launches USB4 IP for TSMC 5nm Process
發表時間 :
24/7 Software's Groundbreaking Business Intelligence Tool Drives Global Growth
發表時間 :
Firmable announces new integration with Salesforce, enhancing the power of Australian B2B data.
發表時間 :
Crown Aesthetics向Cavendish Clinics提供屢獲殊榮的SkinPen®精準微針裝置，協助其升級微針療程設備
發表時間 :
ADQ Announced as the Headline Partner for Abu Dhabi Finance Week
發表時間 :
2025年QS亞洲大學排名
發表時間 :
Anthosa Consulting Expands Partner Ecosystem to Drive Digital Transformation and AI Adoption with Leading Technology Providers
發表時間 :
Biban 2024開幕首日簽署超過180億裡亞爾的協議
發表時間 :
巴基斯坦前所未有的現代和當代視覺藝術和建築展覽在卡塔爾博物館揭幕
發表時間 :
伊斯蘭藝術博物館呈獻開創性展覽，探索摩洛哥的伊斯蘭藝術傳統
發表時間 :
2025年度一千英里耐久賽現已開放報名
發表時間 :
Cyient DLM Wins Long Term Deal with Honeywell Aerospace Technologies to Provide Aircraft Cooling Technology
發表時間 :
Sunseeker Pushes Boundaries with Wireless Smart Lawn Mower at Elevate Conference
發表時間 :
Official Site Now Open for New Smilegate Title "Chaos Zero Nightmare" Revealing the New Promotional Video!
發表時間 :
台鈴在EICMA重磅發布新產品S96MAX，與高效集成電機和快充技術
發表時間 :
BRACCO TRIPLES PRODUCTION OF ITS INNOVATIVE CONTRAST AGENT FOR ULTRASOUND IN GENEVA, INAUGURATING A SECOND FACILITY
發表時間 :
2025 年 4 月 26 日 (星期六) 農曆三月廿九日
A12 藝術空間
TradeAsia 亞洲貿易網 | 開啟全球商機的專業 B2B 貿易平台 Web Builder 智慧型網站大師 | 網站建置的領導品牌
2025 亞洲工業展覽會 台灣五金展(THS) 2025 亞洲電子展覽會 2025 亞洲汽機車零配件展覽會 台灣金屬材料暨精密加工設備展(IMT) 2025 亞洲五金展覽會 2025 亞洲文具及辦公用品展覽會
亞洲貿易展 益陽工業股份有限公司 良英股份有限公司 複成企業股份有限公司 亞洲網址銀行 Bath Sponge, Shopping Bag, Cosmetic Bag Manufacturer - NETBRIDGE
首 頁 我的收藏 搜 尋 新聞發佈